×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Volver a Agenda
Session 2, Track B: Why Canada for Conducting Clinical Trials?
Session Chair(s)
Marie-France Goyer, MSc
Director, Clinical Operations
Abcellera, Canada
Rebecca Barnes, MS
Executive Director
Network of Networks (N2), Canada
This interactive, moderated session will highlight the advantages of conducting clinical trials in Canada. It will begin with short talks from several perspectives: a clinical trials infrastructure organization; a Canadian site; a Sponsor; and a CRO. Following these framing talks, attendees will have the opportunity to engage in an interactive discussion with the session moderator and speakers.
Learning Objective : At the conclusion of this session, participants should be able to:- Recognize some of the factors that make Canada an appealing and competitive country for clinical trials, from different stakeholder perspectives
- Share perspectives on real and perceived barriers to conducting clinical trials in Canada
- Illustrate some of the unique benefits and truths regarding the conduct of clinical trials in Canada that can be used as a unified message to the global market
Speaker(s)
Highlighting the advantages of conducting clinical trials in Canada
Sonia Brodie, MS
Healthtech Connex, Canada
VP Clinical Research
Representative Invited
Clinical Trials Ontario, Canada
Canada’s Competitiveness – CRO Perspective
Representative Invited
IQVIA Canada, Canada
¿Tiene una cuenta?